Affimed NV
NASDAQ:AFMD

Watchlist Manager

Affimed NV

NASDAQ:AFMD

Watchlist

Dividends

Price: 0.1815 USD -34.95%

Market Cap: 750k USD

Activate Unlimited Plan
to continue AFMD research

You've reached your weekly stock limit.

14-day money-back guarantee

Have any thoughts about
Affimed NV?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 0.1815 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

AFMD Alert

Affimed NV

0.1815

-0.0975 (-34.95%)

52 Week Range	0.0851 5.55
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Affimed NV

What unique competitive advantages
does Affimed NV hold over its rivals?

What risks and challenges
does Affimed NV face in the near future?

Provide an overview of the primary business activities
of Affimed NV.

Show me price targets
for Affimed NV made by professional analysts.

Provide an overview of the primary business activities
of Affimed NV.

What unique competitive advantages
does Affimed NV hold over its rivals?

What risks and challenges
does Affimed NV face in the near future?

Summarize the latest earnings call
of Affimed NV.

Show all valuation multiples
for Affimed NV.

Provide P/S
for Affimed NV.

Provide P/E
for Affimed NV.

Provide P/OCF
for Affimed NV.

Provide P/FCFE
for Affimed NV.

Provide P/B
for Affimed NV.

Provide EV/S
for Affimed NV.

Provide EV/GP
for Affimed NV.

Provide EV/EBITDA
for Affimed NV.

Provide EV/EBIT
for Affimed NV.

Provide EV/OCF
for Affimed NV.

Provide EV/FCFF
for Affimed NV.

Provide EV/IC
for Affimed NV.

Show me price targets
for Affimed NV made by professional analysts.

What are the Revenue projections
for Affimed NV?

How accurate were the past Revenue estimates
for Affimed NV?

What are the Net Income projections
for Affimed NV?

How accurate were the past Net Income estimates
for Affimed NV?

What are the EPS projections
for Affimed NV?

How accurate were the past EPS estimates
for Affimed NV?

What are the EBIT projections
for Affimed NV?

How accurate were the past EBIT estimates
for Affimed NV?

Compare the revenue forecasts
for Affimed NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Affimed NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Affimed NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Affimed NV compared to its peers.

Compare the P/E ratios
of Affimed NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Affimed NV with its peers.

Analyze the financial leverage
of Affimed NV compared to its main competitors.

Show all profitability ratios
for Affimed NV.

Provide ROE
for Affimed NV.

Provide ROA
for Affimed NV.

Provide ROIC
for Affimed NV.

Provide ROCE
for Affimed NV.

Provide Gross Margin
for Affimed NV.

Provide Operating Margin
for Affimed NV.

Provide Net Margin
for Affimed NV.

Provide FCF Margin
for Affimed NV.

Show all solvency ratios
for Affimed NV.

Provide D/E Ratio
for Affimed NV.

Provide D/A Ratio
for Affimed NV.

Provide Interest Coverage Ratio
for Affimed NV.

Provide Altman Z-Score Ratio
for Affimed NV.

Provide Quick Ratio
for Affimed NV.

Provide Current Ratio
for Affimed NV.

Provide Cash Ratio
for Affimed NV.

What is the historical Revenue growth
over the last 5 years for Affimed NV?

What is the historical Net Income growth
over the last 5 years for Affimed NV?

What is the current Free Cash Flow
of Affimed NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Affimed NV.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

AFMD Price Targets Summary
Affimed NV

There are no price targets for AFMD.

AFMD Lowest Forecast

Wall Street Target

Not Available

AFMD Average Forecast

Wall Street Target

Not Available

AFMD Highest Forecast

Wall Street Target

Not Available

Lowest

Price Target

Not Available

Average

Price Target

Not Available

Highest

Price Target

Not Available

Affimed NV Competitors:
Price Targets

VCEL

Vericel Corp

45% Upside

1167

Jacobio Pharmaceuticals Group Co Ltd

57% Downside

BPMC

Blueprint Medicines Corp

4% Upside

TLX

Telix Pharmaceuticals Ltd

43% Upside

VCEL

Vericel Corp

45% Upside

1167

Jacobio Pharmaceuticals Group Co Ltd

57% Downside

BPMC

Blueprint Medicines Corp

4% Upside

TLX

Telix Pharmaceuticals Ltd

43% Upside

NTLA

Intellia Therapeutics Inc

272% Upside

ARGX

argenx SE

49% Upside

FYB

Formycon AG

93% Upside

MNKD

MannKind Corp

167% Upside

Revenue
Forecast

Revenue Estimate
Affimed NV

For the last 8 years the compound annual growth rate for Affimed NV's revenue is 1%. The projected CAGR for the next 4 years is 14%.

Past Growth

14%

Estimated Growth

Estimates Accuracy

-7%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Affimed NV

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-4%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Affimed NV

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-57%

Average Miss

What are analyst estimates?

What is AFMD's stock price target?

Not Available

AFMD doesn't have any price targets made by Wall Street professionals.

What is Affimed NV's Revenue forecast?

Projected CAGR
14%

For the last 8 years the compound annual growth rate for Affimed NV's revenue is 1%. The projected CAGR for the next 4 years is 14%.

	Affimed NV NASDAQ:AFMD	0.1815 USD -34.95%
	Cutera Inc NASDAQ:CUTR	0.0969 USD -10.19%
	Rite Aid Corp OTC:RADCQ	0.01 USD -75%
	Dorman Products Inc NASDAQ:DORM	128.09 USD 0.61%

	Franklin Covey Co NYSE:FC	22.1 USD -8.56%
	Mohawk Industries Inc NYSE:MHK	110.84 USD -0.4%
	Ardmore Shipping Corp NYSE:ASC	10.25 USD 0.49%
	ASGN Inc NYSE:ASGN	52.84 USD 1.23%
	Skyworks Solutions Inc NASDAQ:SWKS	78.76 USD 0.74%
	Weatherford International PLC NASDAQ:WFRD	54.15 USD -2.11%

	Johnson & Johnson NYSE:JNJ	156.01 USD 0.29%
	Bank of America Corp NYSE:BAC	48.93 USD 0.45%
	Mastercard Inc NYSE:MA	569.24 USD 1.37%
	Salesforce Inc NYSE:CRM	272.15 USD 1.09%
	Abbvie Inc NYSE:ABBV	189.28 USD -0.77%
	Home Depot Inc NYSE:HD	371.68 USD -0.05%

	Arista Networks Inc NYSE:ANET	102.52 USD 1.37%
	Deckers Outdoor Corp NYSE:DECK	106.2 USD -0.06%
	Visa Inc NYSE:V	358.86 USD 1.31%
	Texas Pacific Land Corp NYSE:TPL	1 075.97 USD 0.38%
	KLA Corp NASDAQ:KLAC	924.58 USD 0.38%
	Manhattan Associates Inc NASDAQ:MANH	199.93 USD 0.61%

	Salesforce Inc NYSE:CRM	272.15 USD 1.09%
	Accenture PLC NYSE:ACN	304.78 USD 0.82%
	ServiceNow Inc NYSE:NOW	1 044.69 USD 3.46%
	Spotify Technology SA NYSE:SPOT	725.05 USD 2.19%
	EOG Resources Inc NYSE:EOG	123.15 USD 0.22%
	Applied Materials Inc NASDAQ:AMAT	191.05 USD 0.55%

Affimed NV
NASDAQ:AFMD